Topics in Clinical Biosecurity: Smallpox
Listed below are all CBN articles on Smallpox published since 2005
- 03-13-2018: Modeling Smallpox in 2018: The Role of the Immunosuppressed Population If smallpox ever recurs, the Increasing percentage of immunocompromised Individuals could both amplify the death rate and complicate vaccination strategies.
- 03-06-2015: An Update on Bioterrorism-Related Conditions
- 05/06/2011. Absence of Smallpox "Take" May Not Indicate Revaccination Failure: Successful vaccination against smallpox is generally determined by inspection of the vaccine site approximately one week after vaccination. It has long been observed that people who are revaccinated have lower rates of vaccine takes.
- 3rd Generation Smallpox Vaccine LC16m8 Proved Safe and Immunogenic. March 20, 2009.
- Update on Smallpox Vaccine. January 8, 2009
- Long-lived Immunity after Smallpox Vaccination. December 5, 2008.
- New Smallpox Vaccine Licensed. September 7, 2007.
- Contact Vaccinia. March 27, 2007.
- Dilution of Smallpox Vaccine, Revisited. March 1, 2007.
- Smallpox Antiviral Effective in Animal Trials. October 23, 2006.
- 500,000 Doses of Attenuated Smallpox Vaccine Delivered to U.S. Government. December 7, 2005.